Call for Papers

Antioxidants & Redox Signaling

Editor-in-Chief: Chandan K. Sen

Latest Impact Factor: 6.337

Antioxidants & Redox Signaling is currently seeking high-quality innovative manuscripts to be published in future issues.

Topics can include but are not limited to:

  • ROS/RNS as messengers
  • Gaseous signal transducers
  • Hypoxia and tissue oxygenation
  • microRNA
  • Prokaryotic systems
  • Lessons from plant biology

Antioxidants & Redox Signaling is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.

The Journal has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.

ARS utilizes 4-6 reviewers for each manuscript to ensure a fair review process. In addition, authors of every manuscript that was rejected following full-length peer review may rescue their work through an open peer review process as part of our signature REBOUND TRACK peer review process.

Benefits of publishing in the Journal:

  • Latest Impact Factor: 6.337
  • Time to First Decision averages just 17 days!
  • Fast and user-friendly electronic submission
  • Rapid, high-quality peer review
  • Diversity of article types
  • Maximum exposure: readership in more than 170 countries
  • Open Access options available


Learn More about this journal